SCHEMBL24670111

SCHEMBL24670111

C#CCCOCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22774658 0.97 CA2 (0.39)
SCHEMBL20370850 0.97 CA2 (0.39)
Hydrochloric Acid SCHEMBL28720024 0.95 CA2 (0.38)
SCHEMBL7132326 0.85
SCHEMBL21070374 0.84
SCHEMBL21070519 0.82 CA2 (0.37)
SCHEMBL18537903 0.82 CA2 (0.42)
SCHEMBL17404787 0.82 CA2 (0.42)
SCHEMBL21441729 0.80 CYP1A2 (0.35)
SCHEMBL13844260 0.77 CA2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725064-B2 Chimeric small molecules for the recruitment of antibodies to cancer cells YALE UNIVERSITY (US) 2023-08-15 US disclosed
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed